Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
Termin
30.06.2026
Opublikowano
26.10.2026
Udzielone
26.10.2026
Preliminary Market Engagement for Real Time Location System (
Przyjmowanie ofert·Oct 19
Purchase of lightsouce
Udzielone·Oct 16
Purchase of Cardiotocography machines
Udzielone·Oct 12
Purchase of ENT Microscopes
Udzielone·Oct 7
Rental of 1 x Interventional Radiology Suite
Udzielone·Oct 6
Linen & Laundry - Managed Services
Udzielone·Sep 29
Histology Reporting
Udzielone·Oct 14
WSFT - Pathology - Bloodtrack software support
Udzielone·Oct 9
WSFT - Pathology - AlinIQ Indexor
Udzielone·Oct 9
WSFT - Pathology - Bloodtrack software support
Udzielone·Oct 1
WSFT - Managed Service - Pathology - Microbiology testing Pro-Lab Diagnostics
Udzielone·Sep 4
Pathology Managed Service for Midlands & East 2 Network
Udzielone·Jul 10
Opswat Metadefender licensing, support and design services
Udzielone·Oct 27
Asbestos surveying and consultancy
Udzielone·Oct 27
ASC Data Platform Development Support
Udzielone·Oct 27
ITEP1273 - Citizen Space -26/28
Udzielone·Oct 27
2026-10-27 09:00 - QBE476 Red Lodge to Innov8 Workshops, Rougham - AWARD
Udzielone·Oct 27
BPB000196 South Mainstream Taxi
Udzielone·Oct 27
Utwórz konto, aby przeanalizować to zamówienie i znaleźć podobne możliwości.